DNA polymerase η mutational signatures are found in a variety of different types of cancer

References

• Watson IR, Takahashi K, Futreal PA, et al. Emerging patterns of somatic mutations in cancer. Nat Rev Genet. 2013;14:703–718. doi:10.1038/nrg3539. PMID:24022702
   PubMed Web of Science ®Google Scholar
• Waddell N, Pajic M, Patch AM, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518:495–501. doi:10.1038/nature14169. PMID:25719666
   PubMed Web of Science ®Google Scholar
• Wood LD, Hruban RH. Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med. 2015;49:13–22. doi:10.4132/jptm.2014.12.26. PMID:25812653
   PubMed Web of Science ®Google Scholar
• Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974;34:2311–2321. PMID:4136142
   PubMed Web of Science ®Google Scholar
• Loeb LA. Human cancers express a mutator phenotype: hypothesis, origin, and consequences. Cancer Res. 2016;76:2057–2059. doi:10.1158/0008-5472.CAN-16-0794. PMID:27197248
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415–421. doi:10.1038/nature12477. PMID:23945592
   PubMed Web of Science ®Google Scholar
• Roberts SA, Gordenin DA. Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer. 2014;14:786–800. doi:10.1038/nrc3816. PMID:25568919
   PubMed Web of Science ®Google Scholar
• Pfeifer GP. How the environment shapes cancer genomes. Curr Opin Oncol. 2015;27:71–77. doi:10.1097/CCO.0000000000000152. PMID:25402978
   PubMed Web of Science ®Google Scholar
• Albertson TM, Ogawa M, Bugni JM, et al. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc Natl Acad Sci U S A. 2009;106:17101–17104. doi:10.1073/pnas.0907147106. PMID:19805137
   PubMed Web of Science ®Google Scholar
• Burns MB, Lackey L, Carpenter MA, et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 2013;494:366–370. doi:10.1038/nature11881. PMID:23389445
   PubMed Web of Science ®Google Scholar
• Heintel D, Kroemer E, Kienle D, et al. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia. 2004;18:756–762. doi:10.1038/sj.leu.2403294. PMID:14961036
   PubMed Web of Science ®Google Scholar
• Qian J, Wang Q, Dose M, et al. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell. 2014;159:1524–1537. doi:10.1016/j.cell.2014.11.013. PMID:25483777
   PubMed Web of Science ®Google Scholar
• Fishel R, Kolodner RD. Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev. 1995;5:382–395. doi:10.1016/0959-437X(95)80055-7.
   PubMed Web of Science ®Google Scholar
• Heitzer E, Tomlinson I. Replicative DNA polymerase mutations in cancer. Curr Opin Genet Dev. 2014;24:107–113. doi:10.1016/j.gde.2013.12.005.
   PubMed Web of Science ®Google Scholar
• Barbari SR, Shcherbakova PV. Replicative DNA polymerase defects in human cancers: consequences, mechanisms, and implications for therapy. DNA Repair (Amst). 2017;56:16–25. doi:10.1016/j.dnarep.2017.06.003. PMID:28687338
   PubMed Web of Science ®Google Scholar
• Scully R. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res: BCR. 2000;2:324–230. doi:10.1186/bcr76. PMID:11250724
   PubMed Web of Science ®Google Scholar
• Masutani C, Kusumoto R, Yamada A, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999;399:700–704. doi:10.1038/21447. PMID:10385124
   PubMed Web of Science ®Google Scholar
• Saini N, Roberts SA, Klimczak LJ, et al. The impact of environmental and endogenous damage on somatic mutation load in human skin fibroblasts. PLoS Genet. 2016;12:e1006385. doi:10.1371/journal.pgen.1006385. PMID:27788131
   PubMed Web of Science ®Google Scholar
• Lynch M. Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A. 2010;107:961–968. doi:10.1073/pnas.0912629107. PMID:20080596
   PubMed Web of Science ®Google Scholar
• Martincorena I, Roshan A, Gerstung M, et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Sci (New York, NY). 2015;348:880–886. doi:10.1126/science.aaa6806.
   Google Scholar
• Washington MT, Johnson RE, Prakash L, et al. Accuracy of lesion bypass by yeast and human DNA polymerase eta. Proc Natl Acad Sci U S A. 2001;98:8355–8360. doi:10.1073/pnas.121007298. PMID:11459975
   PubMed Web of Science ®Google Scholar
• Matsuda T, Bebenek K, Masutani C, et al. Low fidelity DNA synthesis by human DNA polymerase h. Nature. 2000;404:1011–1013. doi:10.1038/35010014. PMID:10801132
   PubMed Web of Science ®Google Scholar
• Matsuda T, Bebenek K, Masutani C, et al. Error rate and specificity of human and murine DNA polymerase eta. J Mol Biol. 2001;312:335–346. doi:10.1006/jmbi.2001.4937. PMID:11554790
   PubMed Web of Science ®Google Scholar
• Pavlov YI, Shcherbakova PV, Rogozin IB. Roles of DNA polymerases in replication, repair, and recombination in eukaryotes. Int Rev Cytol. 2006;255:41–132. doi:10.1016/S0074-7696(06)55002-8. PMID:17178465
   PubMedGoogle Scholar
• Johnson RE, Kondratick CM, Prakash S, et al. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science (New York, NY). 1999;285:263–265. doi:10.1126/science.285.5425.263.
   Google Scholar
• Petljak M, Alexandrov LB. Understanding mutagenesis through delineation of mutational signatures in human cancer. Carcinogenesis. 2016;37:531–540. doi:10.1093/carcin/bgw055. PMID:27207657
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Pavlov YI, Goncearenco A, et al. Mutational signatures and mutable motifs in cancer genomes. Brief Bioinform. 2017. doi:10.1093/bib/bbx049. PMID:28498882
   PubMed Web of Science ®Google Scholar
• Zanotti KJ, Gearhart PJ. Antibody diversification caused by disrupted mismatch repair and promiscuous DNA polymerases. DNA Repair (Amst). 2016;38:110–116. doi:10.1016/j.dnarep.2015.11.011. PMID:26719140
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Pavlov YI, Bebenek K, et al. Somatic mutation hotspots correlate with DNA polymerase eta error spectrum. Nat Immunol. 2001;2:530–536. doi:10.1038/88732. PMID:11376340
   PubMed Web of Science ®Google Scholar
• Zeng X, Winter DB, Kasmer C, et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol. 2001;2:537–541. doi:10.1038/88740. PMID:11376341
   PubMed Web of Science ®Google Scholar
• Supek F, Lehner B. Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes. Cell. 2017;170:534.e23–47.e23. doi:10.1016/j.cell.2017.07.003.
   Web of Science ®Google Scholar
• McCulloch SD, Kokoska RJ, Masutani C, et al. Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity. Nature. 2004;428:97–100. doi:10.1038/nature02352. PMID:14999287
   PubMed Web of Science ®Google Scholar
• Saribasak H, Maul RW, Cao Z, et al. DNA polymerase zeta generates tandem mutations in immunoglobulin variable regions. J Exp Med. 2012;209:1075–1081. doi:10.1084/jem.20112234. PMID:22615128
   PubMed Web of Science ®Google Scholar
• Maul RW, MacCarthy T, Frank EG, et al. DNA polymerase iota functions in the generation of tandem mutations during somatic hypermutation of antibody genes. J Exp Med. 2016;213:1675–1683. doi:10.1084/jem.20151227. PMID:27455952
   PubMed Web of Science ®Google Scholar
• Lee DH, Pfeifer GP. Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J Biol Chem. 2003;278:10314–10321. doi:10.1074/jbc.M212696200. PMID:12525487
   PubMed Web of Science ®Google Scholar
• Rogozin IB, Lada AG, Goncearenco A, et al. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers. Sci Rep. 2016;6:38133. doi:10.1038/srep38133. PMID:27924834
   PubMed Web of Science ®Google Scholar
• Lada AG, Kliver SF, Dhar A, et al. Disruption of transcriptional coactivator Sub1 leads to genome-wide re-distribution of clustered mutations induced by APOBEC in active yeast genes. PLoS Genet. 2015;11:e1005217. doi:10.1371/journal.pgen.1005217. PMID:25941824
   PubMed Web of Science ®Google Scholar
• Taylor BJ, Wu YL, Rada C. Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes. Elife. 2014;3:e03553. doi:10.7554/eLife.03553. PMID:25237741
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014;24:52–60. doi:10.1016/j.gde.2013.11.014.
   PubMed Web of Science ®Google Scholar
• Green MR, Kihira S, Liu CL, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci U S A. 2015;112:E1116–E1125. doi:10.1073/pnas.1501199112. PMID:25713363
   PubMed Web of Science ®Google Scholar
• Temiz NA, Donohue DE, Bacolla A, et al. The somatic autosomal mutation matrix in cancer genomes. Hum Genet. 2015;134:851–864. doi:10.1007/s00439-015-1566-1. PMID:26001532
   PubMed Web of Science ®Google Scholar
• Laffleur B, Denis-Lagache N, Peron S, et al. AID-induced remodeling of immunoglobulin genes and B cell fate. Oncotarget. 2014;5:1118–1131. doi:10.18632/oncotarget.1546. PMID:24851241
   PubMedGoogle Scholar
• Yadav VK, DeGregori J, De S. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection. Nucleic Acids Res. 2016;44:2075–2084. doi:10.1093/nar/gkw086. PMID:26883632
   PubMed Web of Science ®Google Scholar
• Makridakis NM, Reichardt JK. Translesion DNA polymerases and cancer. Front Genet. 2012;3:174. doi:10.3389/fgene.2012.00174. PMID:22973298
   PubMedGoogle Scholar
• CGAN. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi:10.1038/nature11252. PMID:22810696
   PubMed Web of Science ®Google Scholar
• CGARN. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615. doi:10.1038/nature10166. PMID:21720365
   PubMed Web of Science ®Google Scholar
• Roberts SA, Lawrence MS, Klimczak LJ, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45:970–976. doi:10.1038/ng.2702. PMID:23852170
   PubMed Web of Science ®Google Scholar
• Pavlov YI, Rogozin IB, Galkin AP, et al. Correlation of somatic hypermutation specificity and A-T base pair substitution errors by DNA polymerase eta during copying of a mouse immunoglobulin kappa light chain transgene. Proc Natl Acad Sci U S A. 2002;99:9954–9959. doi:10.1073/pnas.152126799. PMID:12119399
   PubMed Web of Science ®Google Scholar
• Mayorov VI, Rogozin IB, Adkison LR, et al. DNA polymerase eta contributes to strand bias of mutations of A versus T in immunoglobulin genes. J Immunol. 2005;174:7781–7786. doi:10.4049/jimmunol.174.12.7781.
   PubMed Web of Science ®Google Scholar
• Bebenek K, Matsuda T, Masutani C, et al. Proofreading of DNA polymerase eta-dependent replication errors. J Biol Chem. 2001;276:2317–2320. doi:10.1074/jbc.C000690200. PMID:11113111
   PubMed Web of Science ®Google Scholar
• Pavlov YI, Nguyen D, Kunkel TA. Mutator effects of overproducing DNA polymerase eta (Rad30) and its catalytically inactive variant in yeast. Mutat Res. 2001;478:129–139. doi:10.1016/S0027-5107(01)00131-2. PMID:11406177
   PubMed Web of Science ®Google Scholar
• Lerner LK, Francisco G, Soltys DT, et al. Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells. Nucleic Acids Res. 2017;45:1270–1280. doi:10.1093/nar/gkw1196. PMID:28180309
   PubMed Web of Science ®Google Scholar
• Ziv O, Zeisel A, Mirlas-Neisberg N, et al. Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin. Nat Commun. 2014;5:5437. doi:10.1038/ncomms6437. PMID:25421715
   PubMed Web of Science ®Google Scholar
• Chan K, Roberts SA, Klimczak LJ, et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet. 2015;47:1067–1072. doi:10.1038/ng.3378. PMID:26258849.
   PubMed Web of Science ®Google Scholar
• Goncearenco A, Rager SL, Li M, et al. Exploring background mutational processes to decipher cancer genetic heterogeneity. Nucleic Acids Res. 2017;45:W514–W522. doi:10.1093/nar/gkx367. PMID:28472504.
   PubMed Web of Science ®Google Scholar